Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Portola Pharmaceuticals begins enrollment in Phase 3 study for Xarelto/andexanet alfa combo
Portola Pharmaceuticals begins enrollment in Phase 3 study for Xarelto/andexanet alfa combo
Portola Pharmaceuticals begins enrollment in Phase 3 study for Xarelto/andexanet alfa combo
Submitted by
admin
on May 12, 2014 - 9:12am
Source:
The Fly on the Wall
News Tags:
Portola Pharmaceuticals
Xarelto
Bayer
Janssen
andexanet alfa
Headline:
Portola Pharmaceuticals begins enrollment in Phase 3 study for Xarelto/andexanet alfa combo
Do Not Allow Advertisers to Use My Personal information
